Medis
Fani Arshinkova is an experienced Key Account Manager in aesthetic dermatology at Medis since February 2023. Prior to this role, Fani held the position of Medical and Sales Representative at NAOS, where responsibilities extended from October 2012 to February 2023. Earlier career experience includes serving as a Manager at DUK1 from October 2006 to October 2012 and as an Administrative Associate at Fintour-BY between May 2004 and September 2006. Fani holds a master's degree in economics from the University of Plovdiv “Paisii Hilendarski” and two bachelor's degrees, one in Agricultural Economics from Agricultural University Plovdiv and another in Accounting from St. Cyril and St. Methodius University of Veliko Tarnovo.
This person is not in the org chart
This person is not in any offices
Medis
1 followers
For 34 years, we have been collaborating with global pharma and biotech partners to bring innovative therapies to patients in Central and Eastern Europe. Despite the region's challenging healthcare systems and complex yet promising markets, our team of 400 employees harnesses its expertise to ensure health equity in these underserved markets. Medis is a member of the World Orphan Drug Alliance (WODA) – a global alliance of full-service regional distributors for orphan and debilitating disease products. WODA covers 152 countries in the following regions: Central and Eastern Europe, Greater China, Israel, Greece, Malta, Cyprus, Latin America, the Middle East, North Africa & Turkey, Switzerland, Australia, New Zealand and South East Asia. Out-licensing: Become our commercialization partner and benefit from advanced, ready-to-launch consumer health products, which are already marketed in 20 countries and are further expanding. More information: www.medis.com/en/international-business/ Our business areas: • Therapeutics • Hospital Care • Consumer Health • Aesthetics Our value to partners: • Direct local presence in 18 CEE countries • Full commercialization • Single point of contact and delivery • Strategic and localized market access approach • Highest compliance standards • Financial and credit excellence Major Partners: • Therapeutics: Bial – Biogen – Besins – HRA Pharma – Mundipharma – Pierre Fabre – Santen – UCB • Hospital Care: Abbott – Aesculap – Asahi Medical – Biotest – B. Braun – Cytosorbents – Paion • Consumer Health: Pleuran – Ricerpharma – Karo Healthcare – Merz – Pohl Boskamp – UP – URGO • Aesthetics: Merz Aesthetics – Crown Aesthetics • Out-licensing partners: Ferrer – Pharmalink – Sarantis – Stada